{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:03:58Z","timestamp":1771542238934,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2000,9,26]]},"DOI":"10.1212\/wnl.55.6.789","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:48:33Z","timestamp":1336916913000},"page":"789-794","source":"Crossref","is-referenced-by-count":210,"title":["Olanzapine and clozapine"],"prefix":"10.1212","volume":"55","author":[{"given":"C.G.","family":"Goetz","sequence":"first","affiliation":[{"name":"From the Departments of Neurological Sciences (Dr. Goetz and L.M. Blasucci) and Preventive Medicine (Dr. Leurgans), Rush Medical College, Rush University, Rush-Presbyterian-St. Luke\u2019s Medical Center, Chicago, IL; and San Marco Neurology (Dr. Pappert), San Marcos, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Blasucci","sequence":"additional","affiliation":[{"name":"From the Departments of Neurological Sciences (Dr. Goetz and L.M. Blasucci) and Preventive Medicine (Dr. Leurgans), Rush Medical College, Rush University, Rush-Presbyterian-St. Luke\u2019s Medical Center, Chicago, IL; and San Marco Neurology (Dr. Pappert), San Marcos, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Leurgans","sequence":"additional","affiliation":[{"name":"From the Departments of Neurological Sciences (Dr. Goetz and L.M. Blasucci) and Preventive Medicine (Dr. Leurgans), Rush Medical College, Rush University, Rush-Presbyterian-St. Luke\u2019s Medical Center, Chicago, IL; and San Marco Neurology (Dr. Pappert), San Marcos, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Pappert","sequence":"additional","affiliation":[{"name":"From the Departments of Neurological Sciences (Dr. Goetz and L.M. Blasucci) and Preventive Medicine (Dr. Leurgans), Rush Medical College, Rush University, Rush-Presbyterian-St. Luke\u2019s Medical Center, Chicago, IL; and San Marco Neurology (Dr. Pappert), San Marcos, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550120077019"},{"key":"e_1_3_1_3_2","first-page":"A370.","volume":"48","year":"1997","unstructured":"Pappert E, Goetz CG, Leurgans S, Stebbins GT. Severity and temporal stability of hallucinations\/illusions in Parkinson\u2019s disease: prospective, longitudinal study. Neurology . 1997; 48: A370.","journal-title":"Neurology"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2227"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.4.669"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.2.515"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01250738"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103143241107"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401003"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050307"},{"key":"e_1_3_1_11_2","first-page":"295","volume":"73","year":"1986","unstructured":"Pakkenberg H, Pakkenberg B. Clozapine in the treatment of tremor. Acta Neurol Scand . 1986; 73: 295\u2013297.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.4.1085"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.11.3.392"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00341-7"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"7","year":"1992","unstructured":"Langston JW, Widner H, Goetz CG. Core assessment program for intracerebral transplantation (CAPIT). Mov Disord . 1992; 7: 2\u201313.","journal-title":"Mov Disord"},{"key":"e_1_3_1_16_2","unstructured":"American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders.   4th ed.   Washington DC:   American Psychiatric Association;   1994."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1305"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.10.1499"},{"key":"e_1_3_1_19_2","first-page":"1195","volume":"50","year":"1998","unstructured":"Friedman JH. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson\u2019s disease. Neurology . 1998; 50: 1195\u20131196. Letter.","journal-title":"Neurology"},{"key":"e_1_3_1_20_2","first-page":"285","volume":"21","year":"1998","unstructured":"Friedman JH, Goldstein S, Jacques C. Substituting clozapine for olanzapine in psychiatrically stable Parkinson\u2019s disease patients: results of an open label pilot study. Clin Neuropharmacol . 1998; 21: 285\u2013288.","journal-title":"Clin Neuropharmacol"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.5.774"},{"key":"e_1_3_1_22_2","first-page":"1183","volume":"50","year":"1998","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Tallon-Barranco A, Orti-Pareja M. Olanzapine can worsen parkinsonism. Neurology . 1998; 50: 1183\u20131184.","journal-title":"Neurology"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199911)14:6<1014::AID-MDS1017>3.0.CO;2-9"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.2.286"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703101110"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.55.6.789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:05:03Z","timestamp":1711555503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.55.6.789"}},"subtitle":["Comparative effects on motor function in hallucinating PD patients"],"short-title":[],"issued":{"date-parts":[[2000,9,26]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,9,26]]}},"alternative-id":["10.1212\/WNL.55.6.789"],"URL":"https:\/\/doi.org\/10.1212\/wnl.55.6.789","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,26]]}}}